Bringing the mucosa to heal with vedolizumab in patients with inflammatory bowel disease

Satimai Aniwan; Edward V. Loftus

doi:10.1093/ecco-jcc/jjx076

Bringing the mucosa to heal with vedolizumab in patients with inflammatory bowel disease

Gastroenterology and Hepatology

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Pages (from-to)	1030-1031
Number of pages	2
Journal	Journal of Crohn's and Colitis
Volume	11
Issue number	9
DOIs	https://doi.org/10.1093/ecco-jcc/jjx076
State	Published - Sep 1 2017

ASJC Scopus subject areas

Gastroenterology

Access to Document

10.1093/ecco-jcc/jjx076

Cite this

@article{6d1785ec5b7644c282f57ebf8e9e4a7b,

title = "Bringing the mucosa to heal with vedolizumab in patients with inflammatory bowel disease",

author = "Satimai Aniwan and Loftus, {Edward V.}",

note = "Funding Information: EVL has consulted for AbbVie, Janssen, Takeda, UCB, Amgen, Pfizer, Eli Lilly, Salix, CVS Caremark and Mesoblast; and has received research support from AbbVie, Janssen, Takeda, UCB, Genentech, Amgen, Pfizer, Receptos, Celgene, Gilead, Seres Therapeutics and Robarts Clinical Trials.",

year = "2017",

month = sep,

day = "1",

doi = "10.1093/ecco-jcc/jjx076",

language = "English (US)",

volume = "11",

pages = "1030--1031",

journal = "Journal of Crohn's and Colitis",

issn = "1873-9946",

publisher = "Elsevier",

number = "9",

}

TY - JOUR

T1 - Bringing the mucosa to heal with vedolizumab in patients with inflammatory bowel disease

AU - Aniwan, Satimai

AU - Loftus, Edward V.

N1 - Funding Information: EVL has consulted for AbbVie, Janssen, Takeda, UCB, Amgen, Pfizer, Eli Lilly, Salix, CVS Caremark and Mesoblast; and has received research support from AbbVie, Janssen, Takeda, UCB, Genentech, Amgen, Pfizer, Receptos, Celgene, Gilead, Seres Therapeutics and Robarts Clinical Trials.

PY - 2017/9/1

Y1 - 2017/9/1

UR - http://www.scopus.com/inward/record.url?scp=85037578042&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85037578042&partnerID=8YFLogxK

U2 - 10.1093/ecco-jcc/jjx076

DO - 10.1093/ecco-jcc/jjx076

M3 - Editorial

C2 - 28575290

AN - SCOPUS:85037578042

SN - 1873-9946

VL - 11

SP - 1030

EP - 1031

JO - Journal of Crohn's and Colitis

JF - Journal of Crohn's and Colitis

IS - 9

ER -

Bringing the mucosa to heal with vedolizumab in patients with inflammatory bowel disease

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this